Biodefense Market in LAMEA would register a CAGR of 6.7% during 2020-2026

Published Date: 3-Feb-2021

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report LAMEA Biodefense Market, published by KBV research, the LAMEA Biodefense Market would witness market growth of 6.7% CAGR during the forecast period (2020-2026).

The Brazil market dominated the LAMEA Biodefense Market by Country in 2019, thereby, achieving a market value of $351.7 million by 2026. The Argentina market would witness a CAGR of 7.6% during (2020 - 2026). Additionally, The UAE market is exhibiting a CAGR of 6.1% during (2020 - 2026).

The Anthrax market dominated the Saudi Arabia Biodefense Market by Product in 2019, growing at a CAGR of 5.7 % during the forecast period. The Smallpox market is estimated to grow at a CAGR of 6.1% during (2020 - 2026). Additionally, The Botulism market would showcase highest CAGR of 8.5% during (2020 - 2026).

The Marketing Asset Management market dominated the South Africa Biodefense Market by Solutions Type 2019, thereby, achieving a market value of $14.7 million by 2026. The Project Management market is showcasing a CAGR of 15.4% during (2020 - 2026). Additionally, The Brand & Advertisement Management market is experiencing a CAGR of 17% during (2020 - 2026).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Xoma Corporation, Altimmune, Inc., Emergent BioSolutions, Inc., Dynavax Technologies Corporation, SIGA Technologies, Inc., Elusys Therapeutics, Inc., Ichor Holdings, Ltd., Cleveland BioLabs, Inc., Bavarian Nordic A/S and Alnylam Pharmaceuticals, Inc.

LAMEA Biodefense Market Segmentation

By Product

  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/nuclear
  • Other Products

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Xoma Corporation
  • Altimmune, Inc.
  • Emergent BioSolutions, Inc.
  • Dynavax Technologies Corporation
  • SIGA Technologies, Inc.
  • Elusys Therapeutics, Inc.
  • Ichor Holdings, Ltd.
  • Cleveland BioLabs, Inc.
  • Bavarian Nordic A/S
  • Alnylam Pharmaceuticals, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Biodefense Market Related Reports:

Global Market

North America Market

Europe Market

Asia Pacific Market

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.